World's Largest Osteoporosis Screening Campaign Changed the Way Osteoporosis is Diagnosed in Finland

KUOPIO, Finland, April 20, 2017 /PRNewswire/ --

The world's largest osteoporosis screening campaign launched by Bone Index Ltd., one of Europe's top new manufacturers of medical devices; Terveystalo, Finland's largest private health care provider; and Hartwall, innovation leader in the beverage industry in Finland, has been a huge success! In a few months, 43,000 Finnish women have fulfilled the risk questionnaire and about 5,000 women have been screened with Bindex®, one of the world's best medical devices in 2016. Bindex® is the world's first pocket-sized diagnostic device for osteoporosis. Screening provides the women accurate information about their osteoporosis status. This will change the way osteoporosis is diagnosed all over the world.

     (Logo: http://photos.prnewswire.com/prnh/20160516/367776LOGO )

"In the US, it would mean that 2.5 million women participated and 300,000 women were measured," says Bone Index's CEO, Dr. Ossi Riekkinen.

"With the risk questionnaire, we can evaluate the osteoporosis risks in one minute and guide the risk patients to Terveystalo for free Bindex measurement done by a nurse immediately. This will increase the cost effectiveness of screening," says Päivi Metsäniemi,  Chief physician, medical development, at Terveystalo.

Undiagnosed osteoporosis is a worldwide challenge. In the USA alone osteoporosis is responsible for two million broken bones every year, costing over 19 billion dollars. Experts forecast that by 2025, the costs will rise to 25.3 billion dollars. One of the biggest challenges is the low availability of osteoporosis diagnostics. "This is why Bindex® is such a game-changer," Dr. Riekkinen says.

"Now Bindex is used in the world's largest osteoporosis screening campaign in Finland, and we are evaluating the best partners for similar campaign in the US. The overall aim is to prevent osteoporotic fractures and improve the quality of life for families in the US," Dr. Riekkinen concludes.

Bone Index Ltd.

Founded in 2011 and based in Kuopio, Bone Index Finland Ltd. specializes in the development of measuring devices for osteoporosis screening and diagnosis.

Terveystalo

Finland's largest private health care provider.

Hartwall Ltd.

Hartwall is the growing leader in the beverage industry. The Novelle Plus product family consists of beverages for which vitamins and minerals have been added for your daily well-being.

For more information: 
Bone Index Ltd.
Dr. Ossi Riekkinen, CEO,
[email protected], +358-50-363-2797 http://www.bindex.fi/en/

Terveystalo
Dr. Päivi Metsäniemi, Chief physician, Medical Development,
[email protected], +358-45-633-8858

Hartwall Ltd.
Export Director Matti Ristola
[email protected], +358-40-865-7440, http://www.hartwall.fi/en

Water Brand manager, Heidi Päiväniemi
[email protected] , +358-40-743-7850

SOURCE Bone Index Ltd.